Substituted pyrimidines as LRKK2 inhibitors

The present disclosure relates generally to compounds of formula (I)or a pharmaceutically acceptable salt, prodrug, deuterated analog, tautomer, stereoisomer, or mixture of stereoisomers thereof and their use as LRRK2 inhibitors.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Feng, Jianwen A, Sweeney, Zachary K, de Vicente Fidalgo, Javier, Estrada, Anthony A, Lyssikatos, Joseph P
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	Feng, Jianwen A Sweeney, Zachary K de Vicente Fidalgo, Javier Estrada, Anthony A Lyssikatos, Joseph P
description	The present disclosure relates generally to compounds of formula (I)or a pharmaceutically acceptable salt, prodrug, deuterated analog, tautomer, stereoisomer, or mixture of stereoisomers thereof and their use as LRRK2 inhibitors.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US11840529B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US11840529B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US11840529B23</originalsourceid><addsrcrecordid>eNrjZNAOLk0qLsksKS1JTVEoqCzKzM1MycxLLVZILFbwCfL2NlLIzMvITMosyS8q5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8aHBhoYWJgamRpZORsbEqAEAaLYphA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Substituted pyrimidines as LRKK2 inhibitors</title><source>esp@cenet</source><creator>Feng, Jianwen A ; Sweeney, Zachary K ; de Vicente Fidalgo, Javier ; Estrada, Anthony A ; Lyssikatos, Joseph P</creator><creatorcontrib>Feng, Jianwen A ; Sweeney, Zachary K ; de Vicente Fidalgo, Javier ; Estrada, Anthony A ; Lyssikatos, Joseph P</creatorcontrib><description>The present disclosure relates generally to compounds of formula (I)or a pharmaceutically acceptable salt, prodrug, deuterated analog, tautomer, stereoisomer, or mixture of stereoisomers thereof and their use as LRRK2 inhibitors.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231212&DB=EPODOC&CC=US&NR=11840529B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25551,76302</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231212&DB=EPODOC&CC=US&NR=11840529B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Feng, Jianwen A</creatorcontrib><creatorcontrib>Sweeney, Zachary K</creatorcontrib><creatorcontrib>de Vicente Fidalgo, Javier</creatorcontrib><creatorcontrib>Estrada, Anthony A</creatorcontrib><creatorcontrib>Lyssikatos, Joseph P</creatorcontrib><title>Substituted pyrimidines as LRKK2 inhibitors</title><description>The present disclosure relates generally to compounds of formula (I)or a pharmaceutically acceptable salt, prodrug, deuterated analog, tautomer, stereoisomer, or mixture of stereoisomers thereof and their use as LRRK2 inhibitors.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAOLk0qLsksKS1JTVEoqCzKzM1MycxLLVZILFbwCfL2NlLIzMvITMosyS8q5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8aHBhoYWJgamRpZORsbEqAEAaLYphA</recordid><startdate>20231212</startdate><enddate>20231212</enddate><creator>Feng, Jianwen A</creator><creator>Sweeney, Zachary K</creator><creator>de Vicente Fidalgo, Javier</creator><creator>Estrada, Anthony A</creator><creator>Lyssikatos, Joseph P</creator><scope>EVB</scope></search><sort><creationdate>20231212</creationdate><title>Substituted pyrimidines as LRKK2 inhibitors</title><author>Feng, Jianwen A ; Sweeney, Zachary K ; de Vicente Fidalgo, Javier ; Estrada, Anthony A ; Lyssikatos, Joseph P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US11840529B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Feng, Jianwen A</creatorcontrib><creatorcontrib>Sweeney, Zachary K</creatorcontrib><creatorcontrib>de Vicente Fidalgo, Javier</creatorcontrib><creatorcontrib>Estrada, Anthony A</creatorcontrib><creatorcontrib>Lyssikatos, Joseph P</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Feng, Jianwen A</au><au>Sweeney, Zachary K</au><au>de Vicente Fidalgo, Javier</au><au>Estrada, Anthony A</au><au>Lyssikatos, Joseph P</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Substituted pyrimidines as LRKK2 inhibitors</title><date>2023-12-12</date><risdate>2023</risdate><abstract>The present disclosure relates generally to compounds of formula (I)or a pharmaceutically acceptable salt, prodrug, deuterated analog, tautomer, stereoisomer, or mixture of stereoisomers thereof and their use as LRRK2 inhibitors.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_US11840529B2
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title	Substituted pyrimidines as LRKK2 inhibitors
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T19%3A44%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Feng,%20Jianwen%20A&rft.date=2023-12-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS11840529B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true